Results 251 to 260 of about 179,831 (305)

Cancer‐Specific Antihuman Podoplanin Antibody chLpMab‐2f Exerts Antitumor Effects Against Pleural Mesothelioma

Cancer Science, EarlyView.
Cancer‐specific antihuman podoplanin antibody chLpMab‐2f exerted antibody‐dependent cellular cytotoxicity and complement‐dependent cytotoxicity against pleural mesothelioma (PM) cell lines. Additionally, chLpMab‐2f inhibited tumor progression in mice with subcutaneously and intrathoracically transplanted human PM cells.
Aito Yoshida, Shinji Abe, Toshihiro Izumi, Satoshi Itakura, Keichiro Yamada, Takuya Wada, Takaaki Yamamoto, Chiemi Sato, Atsushi Mitsuhashi, Hirokazu Ogino, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, Mika K. Kaneko, Yukinari Kato, Yasuhiko Nishioka   +15 more
wiley   +1 more source

Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives. [PDF]

Cells
Yasui H, Doki N, Yan W, Imai K, Ishida T.   +4 more
europepmc   +1 more source

Human CD3 complex is required for the generation of T-cell receptor-like chimeric antigen receptor targeting WT1 in natural killer cells. [PDF]

Cancer Immunol Immunother
Luanpitpong S, Poohadsuan J, Samart P, Kang X, Pratumkaew P, Janan M, Issaragrisil S.   +6 more
europepmc   +1 more source

CD155-based chimeric antigen receptor T cells: a promising immunotherapy for cervical and breast cancer. [PDF]

Front Immunol
Ma J, Zhu W, Zhao R, Shi Q, Yang F, Ding Y, Yuan E, Zhang K, Zhao X.   +8 more
europepmc   +1 more source

Predictive value of MRD monitoring by BCR clonality in the ZUMA‐7 randomized clinical trial for CAR T therapy in r/r lymphoma

British Journal of Haematology, EarlyView.
Brodie Miles, Daqin Mao, Saran Vardhanabhuti, Davide Bedognetti, Simone Filosto, Rhine Shen   +5 more
wiley   +1 more source

New power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M). [PDF]

J Transl Med
Jing J, Chen Y, Chi E, Li S, He Y, Wang B, Shen H, Fan L, Wang J, Shangguan T, Ge X, Jiang Y, Chen Y, Xu C.   +13 more
europepmc   +1 more source

Chimeric Antigen Receptor Cell Therapy: Current Status and Its Potential in Aging and Alzheimer's Disease. [PDF]

Int J Mol Sci
Jurcau MC, Iovanovici CD, Jurcau A, Militaru M, Udrea RB, Comanescu A, Nunkoo VS.   +6 more
europepmc   +1 more source

Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis. [PDF]

Transplant Cell Ther
Nadiminti KV, Ahn KW, Patel J, Lian Q, Bezerra E, Chen A, Ganguly S, Gergis U, Hashmi H, Kharfan-Dabaja MA, Kuruvilla J, Lekakis L, Locke FL, Murthy H, Mousthafa MA, Perales MA, Pophali P, Riedell PA, Shah NN, Wang T, Pasquini M, Hamadani M, Turtle CJ, Herrera AF, Shadman M.   +24 more
europepmc   +1 more source